Strainprint™, the leader in cannabis data collection, is pleased to welcome Dr. Lyle Oberg, Dr. Sana-Ara Ahmed, and Dr. HJ Raza to its Board of Medical Advisors. Strainprint™ works closely with its medical advisors to support patients, enhance research and advance the scientific understanding of cannabinoid therapy.
Strainprint Technologies Ltd. (“Strainprint”) — the leader in cannabis patient and strain efficacy data — is excited to announce the launch of the first ever co-branded version of its revolutionary mobile outcomes-tracking App with Emblem Cannabis Corp.
Strainprint, the leader in cannabis patient and strain efficacy data, is pleased to announce that it has recently closed a private investment round. The Company plans to use proceeds to aggressively build brand and presence in legal North American markets through education and awareness campaigns.
Recently, we were profiled on Yahoo Finance. Watch the video below and read the Yahoo Finance story that profiles our Founder, Stephanie Karasick and the Strainprint App. “Want to try medicinal cannabis but don’t know where to begin? There’s an app for that: strainprint technologies tracks your symptoms, usage and results to share and compare […]
Recently, two members of the Strainprint team were profiled in Lift News for Mother’s Day. The article highlights 3 Canadian moms who open up about their medical cannabis journeys. Have a look at the full article to learn more about moms and cannabis.
Top 4 Benefits of Using a Medical Cannabis Tracking App With a wealth of tracking apps currently available to individuals it’s easy to see how integrating tracking into your everyday life can offer many benefits. At Strainprint we’ve been able to see patients enhance the quality of their day-to-day lives through our new and innovative […]